If you have been reading about Drug affinity complex and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two major principalities survived east of the Weser after the Napoleonic Wars: the Kingdom of Hanover and the Duchy of Brunswick (after 1866 Hanover became a Prussian province; after 1919 Brunswick became a free state). Historically a close tie existed between the royal house of Hanover (Electorate of Hanover) and the United Kingdom of Great Britain and Ireland as a result of their personal union in the 18th century (the personal union was dissolved when Victoria became the Queen of the United Kingdom in 1837 because Hanover did not allow female rulers). West of the River Hunte a "de-Westphalianising process" began in 1815. After the Congress of Vienna the territories of the later administrative regions (Regierungsbezirke) of Osnabrück and Aurich transferred to the Kingdom of Hanover. The Grand Duchy of Oldenburg and the Principality of Schaumburg-Lippe retained state autonomy. Nevertheless, the entire Weser-Ems region (including the city of Bremen) were grouped in 1920 into a Lower Saxon Constituency Association (Wahlkreisverband IX (Niedersachsen)). This indicates that at that time the western administrations of the Prussian Province of Hanover and the state of Oldenburg were perceived as being "Lower Saxon". The forerunners of today's state of Lower Saxony were lands that were geographically and, to some extent, institutionally interrelated from very early on.
Measurements over 10 pCi/L warrant only another short-term test so that abatement measures are not unduly delayed. The EPA has advised purchasers of real estate to delay or decline a purchase if the seller has not successfully abated radon to 4 pCi/L or less. Because the half-life of radon is only 3.8 days, removing or isolating the source will greatly reduce the hazard within a few weeks. Another method of reducing radon levels is to modify the building's ventilation. Generally, the indoor radon concentrations increase as ventilation rates decrease. In a well-ventilated place, the radon concentration tends to align with outdoor values (typically 10 Bq/m3 (0.27 pCi/L), ranging from 1 to 100 Bq/m3 (0.027 to 2.703 pCi/L). The four principal ways of reducing the amount of radon accumulating in a house are:
=== Laminar flow reactor === In a laminar flow reactor, the fluid flows through a long tube or parallel plate reactor and the flow is in layers parallel to the walls of the tube. The velocity of the flow is a parabolic function of radius. In the absence of molecular diffusion, the RTD is
Will Self, novelist (Jewish mother); son of Peter Self, and grandson of Sir Albert Henry Self Charles Gabriel Seligman FRS FRAI (né Seligmann; 24 December 1873 – 19 September 1940) was author, scholar, academic, physician and ethnologist; main ethnographic work described culture of Vedda people of Sri Lanka and Shilluk people of Sudan; was professor at London School of Economics; influential as the teacher of Bronisław Malinowski, E. E. Evans-Pritchard, and Meyer Fortes; was proponent of the Hamitic hypothesis, according to which some civilisations of Africa were thought to have been founded by Caucasoid Hamitic peoples. His work in the 1920s and 1930s is now seen as "white supremacist". Nicholas Serota (born 27 April 1946), author, art historian and curator; served as Director of the Tate from 1988 to 2017; currently Chair of Arts Council England; was previously Director of The Museum of Modern Art, Oxford, and Director of the Whitechapel Gallery, before becoming Director of the Tate; was also Chairman of the Turner Prize jury. Malcolm Shaw (academic) KC (born 1947), British legal academic, author, editor and lawyer; studied at University of Liverpool (LLB), Hebrew University of Jerusalem (LLM) and Keele University (PhD); was the Sir Robert Jennings Professor of International Law at the University of Leicester and taught international law, human rights and equity and trusts; appointed as Senior Fellow at Lauterpacht Centre for International Law at University of Cambridge; Trustee of the British Institute of International and Comparative Law.
Sources: en.wikipedia.org
Air-blast freezing is the oldest and cheapest approach. Food is placed into freezing rooms where the air is cold. Air is either forced ("blasted") onto the food or left static. This setup allows large chunks of food (usually meat or fish) to be more easily processed compared to other methods, but is quite slow. Belt freezers simply put a conveyor belt inside a cold room. Tunnel freezing is a variant of air-blast freezing where food is put onto trolley racks and sent into a tunnel where cold air is continuously circulated. Fluidized bed freezing is a variant of air-blast freezing where pelletized food is blown by fast-moving cold air from below, forming a fluidized bed. The small size of the food combined with the fast-flowing air provides good heat transfer and therefore quicker freezing. Contact freezing uses physical contact other than air to transfer the heat. Direct contact freezing puts the product directly in contact with the refrigerant, while indirect contact freezing uses a plate in between. Plate freezing is the most common form of contact freezing. Food is put between cold metal plates and then lightly pressed to maintain contact. Contact belt freezing combines a conveyor belt with plate freezing. It is usually used for fruit pulps, egg yolk, sauces and soups. Immersion freezing dips the product into a cold refrigerant liquid to freeze it, usually on a conveyor belt. The product may be in direct contact with the liquid, or be separated by a membrane. It can be used for freezing the outer shell of large particles to reduce water loss.
Tofu skin is produced when soy milk is boiled in an open, shallow pan, thus producing a film or skin composed primarily of a soy protein-lipid complex on the liquid surface. Tofu skin is cooked with noodles.
== External links == United States Congress. "Wilmer Mizell (id: M000833)". Biographical Directory of the United States Congress. Career statistics from MLB · Baseball Reference · Baseball Reference (Minors) · Retrosheet · Baseball Almanac Mizell's Infoplease Bio
===== Satisfaction with Life Scale ===== "Happiness" encompasses different emotional and mental phenomena. One method of assessment is Ed Diener's Satisfaction with Life Scale. According to Diener, this five-question survey corresponds well with impressions from friends and family, and low incidence of depression. Rather than long-term, big picture appraisals, some methods attempt to identify the amount of positive affect from one activity to the next. Scientists use beepers to remind volunteers to write down the details of their current situation. Alternatively, volunteers complete detailed diary entries each morning about the day before. A discrepancy arises when researchers compare the results of these short-term "experience sampling" methods, with long-term appraisals. Namely, the latter may not be very accurate; people may not know what makes their life pleasant from one moment to the next. For instance, parents' appraisals mention their children as sources of pleasure, while "experience sampling" indicates parents were not enjoying caring for their children, compared to other activities. Psychologist Daniel Kahneman explains this discrepancy by differentiating between happiness according to the "experiencing self" compared to the "remembering self": when asked to reflect on experiences, memory biases like the Peak-End effect (e.g. we mostly remember the dramatic parts of a vacation, and how it was at the end) play a large role. A striking finding was in a study of colonoscopy patients.
=== Precursors to crosslinking agents === Because of its trifunctionality, CYA is a precursor to crosslinking agents, especially for polyurethane resins and polyisocyanurate thermoset plastics. The experimental antineoplastic drug teroxirone (triglycidyl isocyanurate) is formed by reacting cyanuric acid with 3 equivalents of epichlorohydrin. It works by cross-linking DNA.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.